✦ LIBER ✦

Mutations, methylation and expression of CDKN2a/p16 gene in colorectal cancer and normal colonic mucosa

✍ Scribed by Lech Trzeciak; Ewa Hennig; Jacek Kolodziejski; Marek Nowacki; Jerzy Ostrowski

Book ID: 117466744
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 127 KB
Volume: 163
Category: Article
ISSN: 0304-3835
DOI: 10.1016/s0304-3835(00)00652-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene methylation of SFRP2, P16, DAPK1, H

Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer

✍ Sacide Pehlivan; Mehmet Artac; Tugce Sever; Hakan Bozcuk; Can Kilincarslan; Must 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Prognostic significance of CDKN2A (p16)

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review

✍ Kaori Shima; Katsuhiko Nosho; Yoshifumi Baba; Mami Cantor; Jeffrey A. Meyerhardt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 405 KB

## Abstract A cyclin‐dependent kinase inhibitor CDKN2A (p16/Ink4a) is a tumor suppressor and upregulated in cellular senescence. CDKN2A promoter methylation and gene silencing are associated with the CpG island methylator phenotype (CIMP) in colon cancer. However, prognostic significance of CDKN2A

Effects of X-ray irradiation on methylat

Effects of X-ray irradiation on methylation levels of p16, MGMT and APC genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa

✍ Łukasz Krakowczyk; Joanna K Strzelczyk; Sławomir Blamek; Adam Maciejewski; Stani 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 73 KB

Deletional, mutational, and methylation

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer

✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Infrequent mutations and no methylation

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

✍ Y.-W Lin; C.-H Chen; G.-T Huang; P.-H Lee; J.-T Wang; D.-S Chen; F.-J Lu; J.-C S 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Correlation between methylation status o

Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers

✍ Kenji Kashiwabara; Tetsunari Oyama; Takaaki Sano; Toshio Fukuda; Takashi Nakajim 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 423 KB 👁 1 views

In order to clarify the frequency of p16 gene inactivation and its relationship with Rb expression, immunohistochemical analysis of p16 and Rb proteins was carried out on 82 paraffin-embedded sections of primary non-small cell lung cancers (NSCLCs). From immunohistochemical results, abnormal p16 exp